An interventional study of Fotona4D Pro® treatment followed by daily use of formulations containing MLYAAT-1002® and Fotona4D Pro® treatment followed by daily use of formulations without MLYAAT-1002® in Wrinkle, Skin Laxity and Skin Manifestations, sponsored by Botanee Group Co., Ltd.. Completed at 1 site in China. Open to female participants aged 30 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-16.
Sponsored by Botanee Group Co., Ltd. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This clinical trial aims to learn about the efficacy of MLYAAT-1002® (a proprietary anti-aging complex, MLYAAT is short for "multi-layer anti-ageing technology" ) in female subjects who have newly received the rejuvenation treatment by comparing visual clinical scores, skin attributes measurement and image analysis.
The main expectation it aims to answer are:
29 studies on the registry are indexed under Skin Manifestations; 5 are open to participants now.
This study's enrollment of 37 is below the median of 75 across 23 interventional studies indexed under Skin Manifestations.
Browse Skin Manifestations studies →Botanee Group Co., Ltd. is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
After the Fotana4D Pro® treatment, daily use of the formulation for 28 days: apply one pump of the formulation to the treated side of the face in the morning and evening, respectively.
Combination Product: Fotona4D Pro® treatment followed by daily use of formulations containing MLYAAT-1002®
After the Fotana4D Pro® treatment, daily use of the blank formulation for 28 days: apply one pump of the blank formulation to the control side of the face in the morning and evening, respectively.
Combination Product: Fotona4D Pro® treatment followed by daily use of formulations without MLYAAT-1002®
Each subject will receive a single treatment of the Fotona4D Pro® , followed by the first application of the active comparator on the randomly assigned side of split-face (the treatment side) on the same day, and sequently, will apply the active comparator to this side twice a day for 28 days.
Each subject will receive a single treatment of the Fotona4D Pro® , followed by the first application of the placebo comparator on the randomly assigned side of split-face (the control side) on the same day, and sequently, will apply the placebo comparator to this side twice a day for 28 dayd.
changes in individual typology angle (ITA°) of facial skin
capturing facial images by VISIA-7 (CANFIELD, America) and calculating the ITA
Time frame: Day 0, Day 3, Day 7, Day 14, Day 28
changes in elasticity of facial skin (R2)
measuring gross elasticity (R2) by Cutometer® MPA580 (Courage\&Khazaka, Germany)
Time frame: Day 0, Day 3, Day 7, Day 14, Day 28
changes in elasticity of facial skin (F4)
measuring firmness (F4) by Cutometer® MPA580 (Courage\&Khazaka, Germany)
Time frame: Day 0, Day 3, Day 7, Day 14, Day 28
changes in facial skin topography (SEsm)
evaluating skin smoothness (SEsm) using VisioScan VC20(Courage\&Khazaka,Germany)
Time frame: Day 0, Day 3, Day 7, Day 14, Day 28
changes in facial skin topography (SEw)
evaluating wrinkles (SEw) using VisioScan VC20(Courage\&Khazaka,Germany)
Time frame: Day 0, Day 3, Day 7, Day 14, Day 28
changes in fine line depth of facial skin
evaluating peri orbital fine lines by Primos(CANFIELD, America)
Time frame: Day 0, Day 3, Day 7, Day 14, Day 28
changes in wrinkle depth of facial skin
evaluating crow's feet wrinkles by Primos(CANFIELD, America)
Time frame: Day 0, Day 3, Day 7, Day 14, Day 28
changes in skin thickness of facial skin
measuring skin thickness in µm by Ultrascan UC22(Courage\&Khazaka,Germany)
Time frame: Day 0, Day 3, Day 7, Day 14, Day 28
changes in skin density of facial skin
measuring skin density (ultrasound density in % ) by Ultrascan UC22(Courage\&Khazaka,Germany)
Time frame: Day 0, Day 3, Day 7, Day 14, Day 28
changes in transepidermal water loss (TEWL,in g/m2/h) of facial skin
measuring the loss of water that passes from inside a body through the epidermis to the surrounding atmosphere by Tewameter® MPA580 (Courage\&Khazaka,Germany)
Time frame: Day 0, Day 3, Day 7, Day 14, Day 28
Ran from Sep 2023 to primary completion in Nov 2023, 1 month.
Of 14 interventional studies with no phase under Skin Manifestations, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 17. This study's 1 month is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Botanee Group Co., Ltd.